Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Qatar.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Apidra®
  • Zympass®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Praluent®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Aubagio®
  • Lemtrada®
  • Amaryl®
  • Depakine®
Home | go to homepage
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Apidra®
  • Zympass®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Praluent®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Aubagio®
  • Lemtrada®
  • Amaryl®
  • Depakine®
  • LOGIN
  • REGISTER
  • SEARCH
    • Home
    • Events

    Events

    Stay up to date and register for the latest events and view webinar recordings.

    Filters

    Therapeutical Areas
    Cardiovascular
    Diabetes
    Atopic Dermatitis
    Asthma
    Nasal Polyps
    Rare diseases
    Type of Content
    Watch
    Listen
    Read
    19:24

    Prof. Caprini - Assessing the VTE Risk in Hospital And Beyond

    24:30

    Dyslipidemia Webinars: Optimizing Dyslipidemia management​

    06:58

    VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

    06:13

    VTE Safety Zone: Prof. Le Gal - The Role of Thromboprophylaxis for the Prevention of VTE

    06:58

    VTE Safety Zone: Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

    VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis

    Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management

    17:39

    Soliqua and Unmet Needs Webinar Summary

    100 Years of Insulin

    Dyslipidemia Webisodes: Mortality data with Prof. Tunon

    VTE Safety Zone: Prevention of VTE in Medically ill Patients COVID-19 and BEYOND

    17:39

    Introduction to Gaucher Disease by Prof. Moeenaldeen D. Alsayed

    1
    2
    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE |

    Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information:

    please contact: +971 565776791 or Email: medical-information.gulf@sanofi.com

    To report an adverse event:

    please call: +971 561747001 or Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact: Email: quality.greatergulf@sanofi.com

     

    MAT-QA-2100056/V2/Nov 2021

    • Legal notice
    • Cookie policy
    • Privacy Policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the Qatar.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.